Literature DB >> 10451480

Do HPV-negative cervical carcinomas exist?--revisited.

C S Herrington.   

Abstract

There has been considerable debate regarding the existence of HPV-negative cervical carcinoma. In this issue of the journal, using well-controlled methodology, Walboomers et al. demonstrate that HPV DNA is present in almost all invasive carcinomas in a large multinational study. This indicates that HPV-negative carcinoma is extremely uncommon, if it exists at all. It also implies that HPV testing, if optimally applied, is capable of a sensitivity approaching 100 per cent. This has significant implications for cervical screening. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451480     DOI: 10.1002/(SICI)1096-9896(199909)189:1<1::AID-PATH432>3.0.CO;2-P

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

Review 1.  The pathologist in the 21st century--generalist or specialist?

Authors:  N Kirkham
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

Review 2.  What we could do now: molecular pathology of gynaecological cancer.

Authors:  C S Herrington
Journal:  Mol Pathol       Date:  2001-08

3.  Multifactorial etiology of cervical cancer: a hypothesis.

Authors:  Harry W Haverkos
Journal:  MedGenMed       Date:  2005-11-30

Review 4.  The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.

Authors:  Yi Liu; Hejing Liu; Bo Sheng; Shuya Pan; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Apoptosis       Date:  2022-08-18       Impact factor: 5.561

5.  Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix.

Authors:  Milan Vosmik; Jan Laco; Igor Sirak; Martin Beranek; Eva Hovorkova; Hana Vosmikova; Monika Drastikova; Miroslav Hodek; Zdenek Zoul; Karel Odrazka; Jiri Petera
Journal:  Pathol Oncol Res       Date:  2013-08-03       Impact factor: 3.201

6.  p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal.

Authors:  Rajeev Bala; Benjamin A Pinsky; Andrew H Beck; Christina S Kong; Mark L Welton; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

7.  HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.

Authors:  Liana Mkrtchian; Irina Zamulaeva; Liudmila Krikunova; Valentina Kiseleva; Olga Matchuk; Liubov Liubina; Gunel Kulieva; Sergey Ivanov; Andrey Kaprin
Journal:  J Pers Med       Date:  2021-05-27

8.  Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis.

Authors:  Lin-Bo Gao; Xin-Min Pan; Li-Juan Li; Wei-Bo Liang; Peng Bai; Li Rao; Xiao-Wei Su; Tao Wang; Bin Zhou; Yong-Gang Wei; Lin Zhang
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

9.  Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening.

Authors:  Crispin Kahesa; Julius Mwaiselage; Henry R Wabinga; Twalib Ngoma; Joan N Kalyango; Charles A S Karamagi
Journal:  BMC Public Health       Date:  2008-07-30       Impact factor: 3.295

10.  A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.

Authors:  Yundan Liang; Ruifen Sun; Lijuan Li; Fang Yuan; Weibo Liang; Li Wang; Xinwen Nie; Peng Chen; Lin Zhang; Linbo Gao
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.